Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites b... (ion to standard clinical trial fulfillme...)

Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End

Date:8/7/2008

ion to standard clinical trial fulfillment. Some examples include:

-- Patient-self reporting: Customers capture research or outcomes data directly from patients on touch screen, Internet-platform kiosks in the clinic, prior to the patient visit. The data are used by physicians for care-giving purposes during the same patient visit and are posted to the Velos research database. Some institutions use such patient self-reporting capabilities on-line, enabling patients to report research and outcomes data before and after treatment in accordance with study protocols.

-- Comprehensive research database: Some customers use Velos to capture all patient data, not just clinical trial data. These data are then used for outcomes, research, and publication purposes.

-- Clinical trial networks and consortiums: One Velos customer runs a statewide research consortium with hundreds of users across dozens of sites, fulfilling 50 or so clinical trials. Another group of very large cancer centers uses a federated Velos database grid to conduct dozens of clinical trials that are supported by both government and pharmaceutical sponsors at sites across the U.S.

-- South Korea, with a population about the size of California, uses Velos for cancer research for the entire country.

Velos customers also use Velos eResearch for research budgeting and billing, on-line protocol review meetings, federal reporting, tissue and specimen management, registry reporting, and more.

The company's product design strategy from the start has been "go deep and broad." Medicine and medical research are specialty disciplines, which means products need to be able to "go deep" in supporting particular specialty areas of research. To "go deep" effectively, a system must also support researcher collaborators across many institutions in the same specialty area. At the same time, within any one institution, research is usually conducted in many disease or subspecialty areas w
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Velos to Develop Key System Interface for Clinical Research
2. Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
5. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
6. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
7. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
8. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
9. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
10. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
11. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

Post Your Comments:

Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites b...(ion to standard clinical trial fulfillme...),Health